KENZEN Side Effects

7013149-4 | Hypoglycaemia
on Sep 08, 2010 Female patient from JAPAN , weighting 160.9 lb, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Kenzen dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), NOVONORM (View Novonorm Review and Novonorm Label ).

6768580-9 | Asthenia, Diarrhoea, Eosinophilia, Iron Deficiency, Nausea, Pruritus, Renal Failure, Renal Failure Acute
Patient was taking Kenzen (View Usage). Patient had the following side effects: asthenia, diarrhoea, eosinophilia, iron deficiency, nausea (What is nausea?), pruritus, renal failure, renal failure acute on Jun 04, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with hypertension, pulmonary embolism (What is pulmonary embolism?) and. Kenzen dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), QUESTRAN (Two Times A Day.) (View Questran Review and Questran Label ), TORENTAL (View Torental Review and Torental Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (Every Day.) (View Furosemide Review and Furosemide Label ), NEXIUM (Every Day.) (View Nexium Review and Nexium Label ), FORTIMEL (View Fortimel Review and Fortimel Label ). Patient was hospitalized.

6749105-0 | Accidental Overdose, Hypotension
Adverse event was reported on May 25, 2010 by a Male patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 62 years of age, weighting 202.8 lb, After Kenzen was administered, patient had the following side effects: accidental overdose, hypotension. During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ).

6657245-X | Eosinophilia, Pruritus, Renal Failure, Renal Tubular Disorder
on Mar 22, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with hypertension, pulmonary embolism (What is pulmonary embolism?) and was treated with Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, pruritus, renal failure, renal tubular disorder. Kenzen dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), QUESTRAN (Two Times A Day) (View Questran Review and Questran Label ), TORENTAL (View Torental Review and Torental Label ), NEXIUM (Every Day) (View Nexium Review and Nexium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (Every Day) (View Furosemide Review and Furosemide Label ), FORTIMEL (View Fortimel Review and Fortimel Label ). Patient was hospitalized.


6652798-X | Eosinophilia, Renal Failure
on Mar 18, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with hypertension, pulmonary embolism (What is pulmonary embolism?) and was treated with Kenzen (View Usage). Patient had the following side effects: eosinophilia, renal failure. Kenzen dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), QUESTRAN (Two Times A Day) (View Questran Review and Questran Label ), TORENTAL (View Torental Review and Torental Label ), NEXIUM (Every Day) (View Nexium Review and Nexium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (Every Day) (View Furosemide Review and Furosemide Label ), FORTIMEL (View Fortimel Review and Fortimel Label ). Patient was hospitalized.

6264611-3 | Vascular Purpura
Patient was taking Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: vascular purpura on Jul 01, 2009 from JAPAN Additional patient health information: Male patient , weighting 253.5 lb, was diagnosed with hypertension and. Kenzen dosage: . During the same period patient was treated with CELECTOL (View Celectol Review and Celectol Label ). Patient was hospitalized.

6051208-3 | Hypotension
Adverse event was reported on Jan 15, 2009 by a Female patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 83 years of age, Patient experienced the following unwanted or unexpected effects: hypotension. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREVISCAN (View Previscan Review and Previscan Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ART 50 (View Art-50 Review and Art-50 Label ), CREON (View Creon Review and Creon Label ). Patient was hospitalized.

5868409-7 | Abdominal Pain Upper, Jaundice Cholestatic
on Aug 18, 2008 Male patient from JAPAN , 77 years of age, was diagnosed with hypertension, bronchitis (What is bronchitis?), benign prostatic hyperplasia and was treated with Kenzen (View Usage). Patient had the following side effects: abdominal pain upper, jaundice cholestatic. Kenzen dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), FLUDEX (View Fludex Review and Fludex Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), AMLOR (View Amlor Review and Amlor Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OMIX (View Omix Review and Omix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5799977-1 | Abdominal Pain Upper, Jaundice Cholestatic
on Jun 19, 2008 Male patient from FRANCE , 77 years of age, was diagnosed with hypertension, bronchitis (What is bronchitis?), benign prostatic hyperplasia and was treated with Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: abdominal pain upper, jaundice cholestatic. Kenzen dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), FLUDEX (View Fludex Review and Fludex Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), AMLOR (View Amlor Review and Amlor Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), OMIX (View Omix Review and Omix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5745193-9 | Creatinine Renal Clearance Decreased, Diarrhoea, Urinary Tract Infection
Patient was taking Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: creatinine renal clearance decreased, diarrhoea, urinary tract infection (What is urinary tract infection?) on May 06, 2008 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with hypertension, migraine with aura, hypothyroidism and. Kenzen dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5735107-X | Creatinine Renal Clearance Decreased, Diarrhoea, Urinary Tract Infection
Adverse event was reported on Apr 28, 2008 by a Female patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with hypertension, migraine with aura, hypothyroidism and. Location: FRANCE , 80 years of age, Patient had the following side effects: creatinine renal clearance decreased, diarrhoea, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5704643-4 | Abdominal Pain Upper, Jaundice Cholestatic
on Mar 27, 2008 Male patient from FRANCE , 77 years of age, was diagnosed with hypertension, bronchitis (What is bronchitis?), benign prostatic hyperplasia and was treated with Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: abdominal pain upper, jaundice cholestatic. Kenzen dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), FLUDEX (View Fludex Review and Fludex Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), AMLOR (View Amlor Review and Amlor Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5532993-3 | Erythema Multiforme
on Nov 19, 2007 Male patient from FRANCE , 53 years of age, was diagnosed with hypertension, gout (What is gout?) and was treated with Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme. Kenzen dosage: . During the same period patient was treated with COKENZEN (View Cokenzen Review and Cokenzen Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CHRONADALATE (View Chronadalate Review and Chronadalate Label ). Patient was hospitalized.

5493702-X | Pemphigoid
Patient was taking Kenzen (View Usage). Patient had the following side effects: pemphigoid on Oct 11, 2007 from FRANCE Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with hypertension and. Kenzen dosage: . During the same period patient was treated with ZANIDIP (View Zanidip Review and Zanidip Label ), ATARAX (View Atarax Review and Atarax Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FORLAX (View Forlax Review and Forlax Label ).

5423618-6 | Eosinophilia, Pemphigoid
Adverse event was reported on Aug 07, 2007 by a Female patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , weighting 123.5 lb, After Kenzen was administered, patient had the following side effects: eosinophilia, pemphigoid. During the same period patient was treated with ZANIDIP (View Zanidip Review and Zanidip Label ), ATARAX (View Atarax Review and Atarax Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FORLAX (View Forlax Review and Forlax Label ).

5411392-9 | Aphthous Stomatitis
on Jul 23, 2007 Female patient from FRANCE , 74 years of age, was diagnosed with myocardial infarction and was treated with Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: aphthous stomatitis. Kenzen dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), PLAVIX (View Plavix Review and Plavix Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASIX (View Lasix Review and Lasix Label ), INEGY (View Inegy Review and Inegy Label ). Patient was hospitalized.

5385648-2 | Acquired Epidermolysis Bullosa
on Jul 05, 2007 Female patient from FRANCE , 85 years of age, was diagnosed with hypertension and was treated with Kenzen (View Usage). Patient had the following side effects: acquired epidermolysis bullosa. Kenzen dosage: . During the same period patient was treated with ZANIDIP (View Zanidip Review and Zanidip Label ), ATARAX (View Atarax Review and Atarax Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FORLAX (View Forlax Review and Forlax Label ).

5310184-9 | Atrioventricular Block First Degree, Bundle Branch Block, Hyperkalaemia, Renal Failure
Patient was taking Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: atrioventricular block first degree, bundle branch block, hyperkalaemia, renal failure on Apr 16, 2007 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with cardiomyopathy (What is cardiomyopathy?), diabetes mellitus, hypercholesterolaemia and. Kenzen dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ), LANTUS (View Lantus Review and Lantus Label ), LASIX (View Lasix Review and Lasix Label ), LIPUR (View Lipur Review and Lipur Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5296169-X | Atrioventricular Block First Degree, Bundle Branch Block Left, Condition Aggravated, Heart Rate Decreased, Hyperkalaemia, Renal Failure
Adverse event was reported on Apr 05, 2007 by a Male patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with cardiomyopathy (What is cardiomyopathy?), diabetes mellitus, hypercholesterolaemia and. Location: FRANCE , 74 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block first degree, bundle branch block left, condition aggravated, heart rate decreased, hyperkalaemia, renal failure. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LANTUS (View Lantus Review and Lantus Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ), LASIX (View Lasix Review and Lasix Label ), LIPUR (View Lipur Review and Lipur Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5191045-5 | Anaemia, Fall, Hyperkalaemia, Iatrogenic Injury, Loss Of Consciousness, Malaise, Orthostatic Hypotension, Renal Failure, Stent Placement
on Dec 12, 2006 Male patient from FRANCE , 82 years of age, was diagnosed with acute pulmonary oedema and was treated with Kenzen (View Usage). Patient had the following side effects: anaemia, fall (What is fall?), hyperkalaemia, iatrogenic injury, loss of consciousness, malaise, orthostatic hypotension, renal failure, stent placement. Kenzen dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), PLAVIX (View Plavix Review and Plavix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

5173753-5 | Renal Failure Acute
on Dec 04, 2006 Male patient from FRANCE , 80 years of age, was diagnosed with hypertensive cardiomyopathy, arthropathy, myocardial ischaemia, hypercholesterolaemia, benign neoplasm of prostate and was treated with Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: renal failure acute. Kenzen dosage: . During the same period patient was treated with NUREFLEX (View Nureflex Review and Nureflex Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), KREDEX (View Kredex Review and Kredex Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), XATRAL (View Xatral Review and Xatral Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5164615-8 | Dysphonia, Laryngeal Oedema
Patient was taking Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, laryngeal oedema on Nov 27, 2006 from FRANCE Additional patient health information: Male patient , 85 years of age, weighting 172.0 lb, was diagnosed with hypertension, prophylaxis and. Kenzen dosage: . During the same period patient was treated with EUPHON (View Euphon Review and Euphon Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5089046-0 | Bladder Cancer, Bradycardia, Dehydration, Dialysis, Haemoglobin Decreased, Hyperkalaemia, Hypoglycaemia, Metabolic Acidosis, Rectal Cancer
Adverse event was reported on Aug 18, 2006 by a Male patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with hypertension, diabetes mellitus non-insulin-dependent, atrial fibrillation (What is atrial fibrillation?), insomnia, cardiac failure and. Location: FRANCE , 79 years of age, Patient had the following side effects: bladder cancer (What is bladder cancer?), bradycardia, dehydration, dialysis (What is dialysis?), haemoglobin decreased, hyperkalaemia, hypoglycaemia, metabolic acidosis, rectal cancer. During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), LASILIX (View Lasilix Review and Lasilix Label ), PREVISCAN (View Previscan Review and Previscan Label ), IMOVANE (View Imovane Review and Imovane Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ).

4883361-9 | Agitation, Amyotrophy, Asthenia, Cholestasis, Condition Aggravated, Confusional State, Cytolytic Hepatitis, Gastric Ulcer Haemorrhage, Helicobacter Infection
on Jul 22, 2004 Male patient from FRANCE , 47 years of age, was diagnosed with hypertension and was treated with Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: agitation, amyotrophy, asthenia, cholestasis, condition aggravated, confusional state, cytolytic hepatitis, gastric ulcer haemorrhage, helicobacter infection. Kenzen dosage: . Patient was hospitalized.

4868116-3 | Duodenal Ulcer, Hypokalaemia, Hyponatraemia, Metabolic Acidosis, Renal Tubular Disorder
on Sep 28, 2005 Female patient from FRANCE , 73 years of age, was diagnosed with hypertension, insomnia and was treated with Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal ulcer, hypokalaemia, hyponatraemia, metabolic acidosis, renal tubular disorder. Kenzen dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

4865262-5 | Condition Aggravated, Renal Failure
Patient was taking Kenzen (View Usage). Patient had the following side effects: condition aggravated, renal failure on Dec 15, 2005 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with hypertension and. Kenzen dosage: . During the same period patient was treated with ALDACTAZINE (View Aldactazine Review and Aldactazine Label ). Patient was hospitalized.

4835823-8 | Cholestasis, Hepatic Enzyme Increased, Hepatic Failure
Adverse event was reported on Nov 18, 2005 by a Female patient taking Kenzen (View Usage) (Dosage: ) was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?), tachyarrhythmia and. Location: , 76 years of age, weighting 185.2 lb, After Kenzen was administered, patient had the following side effects: cholestasis, hepatic enzyme increased, hepatic failure. During the same period patient was treated with CARTREX (View Cartrex Review and Cartrex Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ). Patient was hospitalized.

4792449-2 | Duodenal Ulcer, Hypokalaemia, Hyponatraemia, Metabolic Acidosis, Renal Tubular Disorder
on Sep 28, 2005 Female patient from , 73 years of age, was diagnosed with hypertension, insomnia and was treated with Kenzen (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal ulcer, hypokalaemia, hyponatraemia, metabolic acidosis, renal tubular disorder. Kenzen dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

4661788-8 | Chest Discomfort, Chest X-ray Abnormal, Dyspnoea Exertional, Interstitial Lung Disease, Respiratory Failure
on Apr 29, 2005 Male patient from , 71 years of age, weighting 220.5 lb, was diagnosed with ventricular extrasystoles and was treated with Kenzen (View Usage). Patient had the following side effects: chest discomfort, chest x-ray abnormal, dyspnoea exertional, interstitial lung disease, respiratory failure. Kenzen dosage: . During the same period patient was treated with OXEOL (View Oxeol Review and Oxeol Label ), CORDARONE (View Cordarone Review and Cordarone Label ), FORADIL (View Foradil Review and Foradil Label ). Patient was hospitalized.

4639171-0 | Autoimmune Hepatitis, Cytolytic Hepatitis, Prothrombin Time Ratio Decreased
Patient was taking Kenzen (View Usage). After Kenzen was administered, patient had the following side effects: autoimmune hepatitis, cytolytic hepatitis, prothrombin time ratio decreased on Apr 07, 2005 from Additional patient health information: Male patient , 55 years of age, was diagnosed with hypertension and. Kenzen dosage: 8 Mg Qd Po. During the same period patient was treated with ODDIBIL (View Oddibil Review and Oddibil Label ). Patient was hospitalized.

4583866-4 | Cytolytic Hepatitis
Adverse event was reported on Feb 01, 2005 by a Male patient taking Kenzen (View Usage) (Dosage: 8 Mg Qd Po) was diagnosed with hypertension and. Location: , 55 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. During the same period patient was treated with ODDIBIL (View Oddibil Review and Oddibil Label ). Patient was hospitalized.

4546782-X | Amyotrophy, Anal Fissure, Biliary Cyst, Blood Pressure Diastolic Increased, Bradycardia, Cholestasis, Cytolytic Hepatitis, Depression, Gastric Ulcer Haemorrhage
on Dec 30, 2004 Male patient from , 46 years of age, was diagnosed with hypertension and was treated with Kenzen (View Usage). Patient had the following side effects: amyotrophy, anal fissure, biliary cyst, blood pressure diastolic increased, bradycardia, cholestasis, cytolytic hepatitis, depression (What is depression?), gastric ulcer haemorrhage. Kenzen dosage: 8 Mg Qd Po. Patient was hospitalized.